Calliditas Therapeutics AB's intangible assets is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2024), CALT shows a intangible assets of $0. That compares with $520M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CALT's intangible assets is now $0 (was $520M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Calliditas Therapeutics AB is outperforming or lagging.
Tracking CALT's intangible assets over time shows whether Calliditas Therapeutics AB is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $520M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this intangible assets page, Stockcircle has Calliditas Therapeutics AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $0) with ownership activity and broader fundamentals.
Calliditas Therapeutics AB's intangible assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.